Journal
CLIMACTERIC
Volume 17, Issue 5, Pages 580-582Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/13697137.2014.883244
Keywords
SURGICAL MENOPAUSE; COGNITIVE DECLINE; ALZHEIMER'S DISEASE; WOMEN'S HEALTH INITIATIVE MEMORY STUDY; HORMONE REPLACEMENT THERAPY
Categories
Ask authors/readers for more resources
Aging is the strongest risk factor for cognitive decline. The perimenopausal period puts women in a more vulnerable state in regard to certain functions such as memory. Also, the Women's Health Initiative Memory Study (WHIMS) pointed at some cognitive adverse effects of postmenopausal hormone therapy, but these results were not relevant for the peri- and early menopause since WHIMS recruited women above the age of 65 years. The 'window of opportunity' theory, pointing at potential protective effects of postmenopausal hormone therapy in the early menopause, mainly applies to coronary artery disease, but clinical data on neuroprotection by estrogen are not consistent. In view of a recent publication, the following article discusses the issue of menopause and cognitive decline, with a focus on possible associations with surgical menopause.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available